Gene Therapy Landscape Trends: An Interview with Forge Biologics CEO, Tim Miller, Ph.D. (Rx for Biotech)
Related Articles
September 29, 2026
TECPR2 Research Foundation and Forge Biologics Announce AAV Development and Manufacturing Partnership
“That mission has brought together an incredible group of scientists and partners who believe, as we do, that children with ultra-rare diseases deserve the...
July 21, 2026
Restore Vision and Forge Announce AAV Manufacturing Partnership
“Providing a new visual restoration treatment option for patients living with retinitis pigmentosa is central to our mission,” said Yusaku Katada, M.D.,...
June 16, 2026
Skylark Bio and Forge Announce Strategic AAV Development and cGMP Manufacturing Partnership
Under the partnership, Forge is providing Skylark with process development, current good manufacturing practice (cGMP) manufacturing, and analytical...
May 11, 2026
Forge Announces Seven Presentations at the ASGCT 29th Annual Meeting
“At ASGCT, we’re proud to showcase how our FUEL™ platform is enabling more doses per batch, improving scalability for broader...